Histamine Promotes the Development of Monocyte-Derived Dendritic Cells and Reduces Tumor Growth by Targeting the Myeloid NADPH Oxidase
Open Access
- 15 May 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 194 (10) , 5014-5021
Abstract
The efficiency of immune-mediated clearance of cancer cells is hampered by immunosuppressive mediators in the malignant microenvironment, including NADPH oxidase–derived reactive oxygen species. We aimed at defining the effects of histamine, an inhibitor of the myeloid NADPH oxidase/NOX2, on the development of Ag-presenting dendritic cells (DCs) from myeloid precursors and the impact of these mechanisms for tumor growth. Histamine was found to promote the maturation of human DCs from monocytes by increasing the expression of HLA-DR and costimulatory molecules, which resulted in improved induction of Th cells with Th0 polarity. Experiments using wild-type and NOX2-deficient myelomonoblastic cells showed that histamine facilitated myeloid cell maturation only in cells capable of generating reactive oxygen species. Treatment of mice with histamine reduced the growth of murine EL-4 lymphomas in parallel with an increment of tumor-infiltrating DCs in NOX2-sufficient mice but not in NOX2-deficient (gp91phox−/−) mice. We propose that strategies to target the myeloid NADPH oxidase may facilitate the development of endogenous DCs in cancer.Keywords
This publication has 41 references indexed in Scilit:
- Re(de)fining the dendritic cell lineageNature Immunology, 2012
- Combinatorial roles for histamineH1‐H2andH3‐H4receptors in autoimmune inflammatory disease of the central nervous systemEuropean Journal of Immunology, 2012
- Coordinated regulation of myeloid cells by tumoursNature Reviews Immunology, 2012
- Regulation of cancer cell metabolismNature Reviews Cancer, 2011
- Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cellsNature Medicine, 2010
- Lipid accumulation and dendritic cell dysfunction in cancerNature Medicine, 2010
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- Numerical and functional defects of blood dendritic cells in early- and late-stage breast cancerBritish Journal of Cancer, 2007
- Dendritic cell dysfunction in cancer: A mechanism for immunosuppressionImmunology & Cell Biology, 2005
- Mechanisms and functional significance of tumour-induced dendritic-cell defectsNature Reviews Immunology, 2004